The HTRS/ATHN DREAM Award supports promising trainees and early-career investigators conducting research in non-malignant hematology with an emphasis on hemostasis and thrombosis. The award is designed to foster the development of new clinical investigators and future academic leaders in the field.
About the Award
The DREAM Award provides research funding for clinical fellows, junior faculty, and other qualified candidates conducting mentored patient-oriented research in bleeding and clotting disorders supported by the ATHN Data Warehouse and ATHN Study infrastructure. The program aims to advance understanding and treatment of rare bleeding and clotting disorders while supporting the career development of clinical investigators.
Eligibility Criteria
Eligible applicants include clinical fellows and junior faculty within five years of fellowship completion who are interested in conducting mentored research projects using ATHN resources. Applicants must be based in the U.S. and affiliated with an ATHN-affiliated institution.
Application Process
The application process includes submission of a Letter of Intent, followed by an invitation to submit a full application if selected. Applications are reviewed by the HTRS/ATHN DREAM Award Review Committee, and award recipients are selected based on the scientific merit of their proposals and their commitment to careers in hemostasis and thrombosis research.
At a Glance
- Funding: Research funding for mentored patient-oriented research
- Eligibility: Clinical fellows and junior faculty within five years of fellowship completion
- Focus: Research using ATHN Data Warehouse and Study infrastructure
- Next Application Deadline: Stay Tuned!
- Contact: [email protected]
